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Abstract
Objective: To determine the epidemiological profile of malignant melanoma cases treated at the National Institute 
for Neoplastic Diseases “Dr. Eduardo Caceres Graziani” (INEN) over the period 1952 to 2008. 
Study Design: All clinical records �ith complete data of patients presenting a histopathological diagnosis of ma-
lignant melanoma of the oral cavity �ere revie�ed. Data such as age, gender, location, tumor size, disease length, 
presence of metastasis, treatment received and year of admission �ere recorded.
Results: During the study period 97 cases �ere found. The average age of patients �as 52.85±1.6 years old mostly 
bet�een 50 and 59 years old; the predominant gender �as the female. The most common location �as the palate 
and there �as 58.8% of cases �ith a tumor size bigger than or equal to 4 cm. The length of the disease in 38.1% of 
the cases �as longer than a year and in great part of the cases (69.1%) there �as no metastasis. The treatment of 
choice �as the surgery plus radiotherapy in 38.1% of the cases. According to the admission date it �as also noted 
that the number of cases is increasing.
Conclusion: The results of this study demonstrate a late diagnosis and an increasing frequency of this neoplasia 
in the oral cavity.
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Introduction
The malignant melanoma of the oral cavity is a neo-
plasia developed from melanocytic cells that are in the 
basal layer of the mucosa (1), its incidence is of 1.2 cases 
per 10 million inhabitants per year (2), �ith a variation 
bet�een 0.2% to 8% of all the melanomas (3,4) and 0.5% 
of all the malignant neoplasias of the oral cavity (5).
Its etiology is unkno�n, although sometimes it is placed 
on pre-existing long-term melanosis involving 33 to 
55% of the mucosal melanomas of the head and neck (6), 
other possible etiological factors for this neoplasia are: 
mechanical trauma such as denture irritation (7), use of 
tobacco, exposure to formaldehyde (8) and alcohol. 
Most cases occur bet�een the fourth and the seventh 
decade of life, �ith an average of 55-57 years old (9), not 
very frequently belo� 30 years old (10). Apparently the 
malignant melanoma of the oral cavity has a predilec-
tion for the male gender (8), in a male-female ratio of 
2:1 (11,12). The areas in �hich they appear in order of 
frequency are: the hard palate (�here 40% of the cases 
have been reported) (2), follo�ed by upper gingival mu-
cosa (13), lo�er gingival mucosa, buccal mucosa, tongue 
and floor of mouth (14). The clinical characteristics are 
variable, such as macular lesions, plate (�ith horizontal 
gro�th, �hich often correspond to melanomas in situ 
in the histopathologic exam) and nodular (�ith clinical 
ulceration, usually of an invasive type or combined at 
a microscopic level) (15); their colors vary from dark 
blue to black and their edges are regular or irregular. 
The symptoms of the oral mucosal melanoma include: 
bleeding (referred to in the diagnosis as the most fre-
quent sign) (10), pain (it often appears late) and presence 
of melanotic pigmentation (in one third of the patients 
before the diagnosis) (16). 
Unlike the cutaneous melanoma in the oral mucosa, 
there is no well-defined clinical and pathological clas-
sification (14), that is, Clark’s criteria for the invasion 
level and the prognosis of the cutaneous melanoma are 
not applicable to oral melanomas due to the lack of his-
tological points of reference similar to the papillary and 
reticular dermis (17), nevertheless, some studies have 
compared oral melanomas �ith the acral lentiginous 
melanoma and �ith the cutaneous nodular melanoma 
(2). Most authors use the classification of the Western 
Society of Teachers of Oral Pathology (WESTOP), 
�hich divides them into a relatively simple system ac-
cording to its histopathological pattern in: (a) melanoma 
in situ, delimited to the epidermis and its junction �ith 
the connective tissue; (b) invasive melanomas, in �hich 
the neoplasia extends into the connective tissue and (c) 
melanomas �ith a combined pattern bet�een invasive 
and in situ (18,19).
Histologically it is characterized by the proliferation of 
atypical melanocytes �ith a �ide variety of shapes, in-
cluding the one of the spindle, of plasmacytoid cells, 
clear cells and some epithelioid cells (18), located along 
the junction bet�een the epithelial and the connective 
tissue, as �ell as invading the connective tissue (2). It 
also describes histological stages of the oral malignant 
melanoma in 3 phases: Stage I primary site, Stage II �ith 
lymph node metastasis and Stage III �ith distant metas-
tasis (20). The immunohistochemistry has referred pos-
itivity in a varying level for the antigens related to the 
melanoma: NKI/C-3, S-100 protein, gp100 (HMB-45), 
Mart-1 (Melan-A) (21), vimentin, tyrosinase and micro-
phthalmia transcription factor (MiTF) that are useful 
in the diagnosis. The vimentin is the most consistent, 
but the less useful for the diagnosis; the S-100 protein 
positivity is nonspecific, but due to the fact that it is 
negative in most of the tumors that are considered in the 
differential diagnosis, this stain is very important; the 
HMB-45 is a much more specific marker than protein 
S-100; the Melan-A is positive in approximately 80% of 
melanomas and MiTF positivity is above the 90% (22). 
The oral melanoma has a metastatic predilection for 
lymphonodes (18), lungs, liver, brain and bones.
The treatment of choice of the oral melanomas consists 
of the complete surgical resection of the lesion �ith 
safety margins, additionally, radiotherapy and chemo-
therapy can be used (23,24).
It is assumed that the �orst prognosis of oral mucosal 
melanoma �ith regard to the cutaneous melanoma is 
due to a late diagnosis, to differences in its histopatho-
logical behavior, to the increased trend to deep invasion, 
to the early hematogenous metastases, to the anatomical 
peculiarities of the region with difficulty in the surgi-
cal resection �ith disease-free margins (25) and to the 
absence of standardized treatment protocols (14). The 
prognosis of this lesion is poor �ith a survival rate at 
5 years for patients �ith melanoma of the oral cavity 
�ithin a range of 15-38% after the diagnosis (26). 
Regarding the melanoma of the oral cavity, most of the 
available information on its clinical and epidemiologi-
cal features comes from a series of small cases, so that 
the kno�ledge of the features of this pathology in larger 
populations are of great meaning for the kno�ledge of 
the natural history of this lesion.
Material and Methods
The present study is descriptive, retrospective, trans-
versal and of a series of cases. The study sample cor-
responds to patients �ith clinical records that had an 
anatomopathological diagnosis of melanoma of the oral 
cavity treated in the National Institute for Neoplas-
tic Diseases “Dr. Eduardo Cáceres Graziani” (INEN) 
over the period 1952 to 2008. The information �as col-
lected in data collecting forms especially prepared for 
this study, for the database Microsoft Excel program 
�as used for its further statistical analysis in Statistical 
Package for Social Sciences (SPSS) version 15.0. Tables 
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of frequencies �ere made for the descriptive analysis of 
each variable, the percentages �ere indicated.
Results
This revie� included 97 cases of oral melanoma treated 
in the National Institute for Neoplastic Diseases “Dr. 
Eduardo Cáceres Graziani” (INEN) over the period 
1952 to 2008. The average age group of this population 
group �as found in 52.85±1.6 years, in a range bet�een 
13 and 96 years old, most cases are observed bet�een 
50 and 59 years old (26.8%). The greatest frequency of 
patients �ith oral melanoma is in the female gender �ith 
a 52.6%, the male:female ratio �as 0.9:1. The greatest 
frequency of location �as in the palate in 47.4% of cas-
es, follo�ed by the upper alveolar ridge �ith 27.8%, the 
lowest percentage regarding site was found on the floor 
of the mouth in only 1.0%. With regard to the tumor 
size, an average of 4.26 cm �as found in a range of 0.5 
to 10 cm, the great part of patients 58.8% present tumors 
equal to more than 4 cm. (Figs. 1 and 2). The 38.1% of 
the cases had disease length of more than 1 year, fol-
lo�ed by patients �ith less than 3 months (30.9%). 
The type of treatment generally used �as the surgical 
complemented �ith radiotherapy (38.1%), follo�ed by 
surgical treatment alone (21.6%). Most patients did not 
present metastasis (69.1%), representing more than t�o 
thirds of the population studied. The percentage of cas-
Fig. 1. Clinical setting of a 31-year-old patient �ith oral melanoma in 
hard palate �ith a 7-year disease length.
Fig. 2. Female 44-year-old patient �ith oral melanoma in tongue 
�ith a 2-year disease length.
Indicators Category Nº % Patients 
Age
From 10 to 19 years 
From 20 to 29 years 
From 30 to 39 years 
From 40 to 49 years 
From 50 to 59 years 
From 60 to 69 years 
From 70 to 79 years 
From 80 to 89 years 
From 90 to 99 years 
No records 
02
03
16
12
26
22
12
00
01
03
(02.1%) 
(03.1%) 
(16.5%) 
(12.4%) 
(26.8%) 
(22.7%) 
(12.4%) 
(00.0%) 
(01.0%) 
(03.1%) 
         Gender 
Male 
Female 
46
51
(47.4%) 
(52.6%) 
Lesion location 
Palate 
Upper alveolar ridge  
Lo�er alveolar ridge  
Tongue
Floor of the mouth  
Buccal mucosa  
Lips
46
27
11
05
01
03
04
(47.4%) 
(27.8%) 
(11.3%) 
(05.2%) 
(01.0%) 
(03.1%) 
(04.1%) 
Tumor size Less than 4 cm 
More than 4 cm 
40
57
(41.2%) 
(58.8%) 
Disease length 
less than 3 months 
From 3 to 6 months 
From 7 to 12 months 
More than 1 year  
Undetermined 
30
18
11
37
01
(30.9%) 
(18.6%) 
(11.3%) 
(38.1%) 
(01.0%)
Type of treatment 
Surgical 
Surgical �ith radiotherapy 
Chemotherapy 
Chemotherapy �ith radiotherapy 
Radiotherapy  
Surgical �ith chemo.and radio. 
Surgical �ith chemotherapy 
Without treatment 
No records 
21
37
01
03
15
01
02
11
06
(21.6%) 
(38.1%) 
(01.0%) 
(03.1%) 
(15.5%) 
(01.1%) 
(02.1%) 
(11.3%) 
(06.2%) 
Metastasis Presents  No presents 
30
67
(30.9%) 
(69.1%) 
Survival status 
Live
Deceased 
Untracked 
04
20
73
(04.1%) 
(20.6%) 
(75.3%) 
Table 1. Distribution of study indicators according to categories 
in patients �ith oral melanoma of the National Institute for Neo-
plastic Diseases “Dr. Eduardo Caceres Graziani”, Lima, Peru, 
over the period 1952-2008.
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es lost sight of �as 75.3%, of patients �ho died of 20.6% 
and 4.1% patients alive, therefore could not perform the 
respective statistical analysis of survival. (Table 1). It 
�as found that there is a trend to the increase of the 
number of cases as the time goes by, a greater percent-
age of cases �as observed in 2008 (6.8%), follo�ed by 
the year 2007 (6.2%) (Fig. 3).
Discussion
The melanoma of the oral cavity is not so frequent ma-
lignant neoplasia and it accounts for 0.2 to 8% of all 
the melanomas affecting the organism (3). It presents 
a poor prognosis due to several characteristics such as: 
remaining asymptomatic for a long time, which justifies 
its late discovery (14). The edges do not have the typi-
cal induration of the carcinomas resulting difficult to be 
recognized as malignant and also the rich vasculature of 
the area contributes to its spreading.
In the present study 97 cases of oral melanoma treated 
in the National Institute for Neoplastic Diseases “Dr. 
Eduardo Cáceres Graziani” (INEN) over a period of 56 
years (1952-2008) are reported and described. This is an 
important and significant sample since it took place in 
an institution specialized in malignant neoplasias, it is a 
referential center at national level. 
The average age of the cases studied �as 52.85 years 
old, which agrees with Chidzonga’s et al. study (24) 
in �hich the average age �as 56 years old, similar to 
Lopez-Graniel et al. study (15) �here the sixth decade 
of life is the average of patients �ith oral melanoma. 
Doval et al. (27) and Tanaka et al. (28) state that the 
oral melanoma is more frequent in people older than 
40 years old, agreeing �ith this study, in �hich 75% of 
the cases �ere older than 40 years old, �hile the high-
est prevalence in the range of 50-59 years old (26.8%), 
agreeing �ith Rapidis et al. (10) �ho mentions that this 
disease is rare before the age of 30.
This study determined that there is a slight female pre-
dominance (52.6%), as well as in the results of Meleti’s 
et al. study (21), ho�ever, the revie� of the literature 
finds a male predominance.
It �as noted that the location of the most frequent le-
sion �as in the palate (47.4%), follo�ed by the upper 
maxillary mucosa (27.8%), finding relation with that 
reported by Meleti et al. (29) �ho describes 41 of 119 
cases �ith lesion in the palate (34.4%), follo�ed by the 
Fig. 3. Number of cases of oral melanoma as per year. National Institute for Neoplastic Diseases "Dr. Eduardo Caceres 
Graziani, Lima, Peru (1952-2008).
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upper maxillary mucosa; as in Doval’s et al.  research 
(27) �ho points out that from 14 cases, 11 had a lesion 
in the palate. 
Regarding the tumor size of the lesion the bigger and 
equal to 4 cm �as frequent in 57 patients (58.8%), this 
result is related to Lopez-Graniel et al. study (15) in 
�hich 66.6% of cases had a size of 4 cm or more.
Most cases presented a disease length longer than 1 year 
(38.1%), the patients referred that they did not feel pain, 
some of them mentioned that they had a mark for sev-
eral years and as the time �ent by it increased in size 
until they felt discomfort, �as observed that the cases 
occurred more frequently after 6 months the disease 
started (68.75%). 
A complete surgical excision �ith radiotherapy �as the 
type of treatment of choice (38.1% of cases), coinciding 
with Doval’s et al. study (27).
Tanaka et al. (28) mentioned that of 35 cases examined, 
18 had metastasis (52.43%), in this studied population, 
only a third part of the cases developed metastasis 
(30.9%).
Lopez-Graniel et al. (15) reports that only 6.6% of all 
the cases studied survived more than 5 years, although, 
the survival time in this study could not be performed 
since the information of the clinical records �as incom-
plete.
In conclusion, over the years a continuous increase of 
melanoma cases in the oral cavity �as observed �ithin 
the period studied presenting higher prevalence in the 
sixth decade of life and being most often located in the 
palate. Moreover, it �as found that at the moment of the 
diagnosis the tumor size �as bigger than or equal to 4 
cm. and the excisional surgery complemented �ith ra-
diotherapy �as the treatment most used in this popula-
tion group. Since many medical records had no updated 
follo�-up records of patients the survival �as not pos-
sible to be determined. The results of this study suggest 
that an early diagnosis is required to improve the prog-
nosis of patients. 
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